Tomazine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tomazine

Understanding Tomazine

Tomazine is a pharmaceutical medication commonly categorized within the class of drugs known as antihistamines. It is primarily utilized to manage symptoms associated with various allergic reactions and certain respiratory conditions. By interacting with specific receptors in the body, the medication works to counteract the effects of histamine, a natural substance produced during an immune response.

Mechanism of Action

At a physiological level, Tomazine functions as a selective antagonist. It targets H1 receptors, which are located throughout the body in smooth muscle, vascular endothelial cells, and the central nervous system. When these receptors are triggered by histamine, they cause common allergy symptoms such as swelling, itching, and increased mucus production. Tomazine binds to these receptors without activating them, effectively blocking histamine from attaching and preventing the onset of these symptoms.

Primary Applications

The medication is most frequently indicated for the following conditions:

  • Allergic Rhinitis: Relief of sneezing, runny nose, and itchy or watery eyes caused by seasonal or perennial allergies.
  • Chronic Urticaria: Management of persistent skin reactions, such as hives or itchy rashes, that do not have an immediate external cause.
  • General Allergic Responses: Mitigation of minor reactions to environmental triggers like pollen, pet dander, or dust mites.

Physical Characteristics and Composition

Tomazine is typically formulated for oral administration. While the specific inactive ingredients may vary depending on the manufacturer, the active chemical compound remains consistent to ensure therapeutic intent. The medication is designed to be absorbed through the gastrointestinal tract, eventually reaching peak concentrations in the bloodstream to provide systemic relief from allergic symptoms.

Regulatory References

  1. Hydroxyzine: MedlinePlus Drug Information

What side effects are possible with Tomazine?

Possible Side Effects and Safety Information

The safety profile of Tomazine (Cetirizine Hydrochloride) is formally documented by regulatory authorities, with adverse reactions categorized by frequency and the physiological systems affected.

Common Adverse Reactions

Reactions classified as Common (occurring in ge 1/100 to < 1/10 individuals) primarily involve the Nervous System and General Disorders. These include somnolence (drowsiness), headache, fatigue, and dizziness. Gastrointestinal effects such as dry mouth and nausea, and respiratory findings such as pharyngitis (sore throat), are also frequently reported.

System-Organ Class Common Adverse Reactions
Nervous System Disorders Somnolence, Headache, Dizziness
General Disorders Fatigue
Gastro-intestinal Disorders Dry mouth, Nausea

Less Common and Serious Reactions

Uncommon reactions include agitation, pruritus (itching), and rash. Rare reactions (ge 1/10,000 to < 1/1,000) documented in the label include hypersensitivity reactions, convulsions, tachycardia, and abnormal hepatic function. Anaphylactic shock and thrombocytopenia are classified as Very Rare occurrences.

Safety Considerations and Constraints

Official safety information details constraints for specific populations: caution is advised for individuals with renal impairment or hepatic impairment due to altered drug clearance. Furthermore, caution is warranted in patients with a predisposition to urinary retention. A unique time-related safety pattern has been documented where severe pruritus or urticaria may be reported after long-term use is discontinued.

Due to the potential for central nervous system effects like somnolence, due caution should be exercised regarding activities requiring mental alertness.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Tomazine (Cetirizine Hydrochloride) overdose is defined by specific manifestations and strictly mandated emergency actions. Symptoms are generally cited following ingestion of doses at least five times the recommended daily amount.

Documented Manifestations and Severe Effects

Clinical manifestations are categorized by regulatory authorities, with a focus on the Central Nervous System (CNS). Effects such as somnolence, confusion, stupor, dizziness, malaise, and tremor are documented. Severe systemic effects cited in the official profile include tachycardia (fast heart rate), urinary retention, and mydriasis (pupil dilation). Population-specific notes indicate that infants and children may first exhibit restlessness and irritability before the onset of drowsiness.

Emergency Response and Management

Immediate medical attention is officially required in the event of a suspected overdose. The regulatory guidance explicitly mandates individuals to seek emergency medical help or contact a Poison Control Center right away.

Management is defined exclusively as symptomatic and supportive treatment. It is formally stated in regulatory documents that no known specific antidote to Cetirizine exists. Furthermore, the substance cannot be effectively removed by dialysis. Procedures such as gastric lavage may be considered shortly after ingestion to support elimination.

Therapeutic Uses of Tomazine

What Tomazine Treats: Main Uses and Benefits

Tomazine is commonly used in therapeutic contexts where supportive symptomatic relief is needed to address symptoms related to heightened physiological activity. It is generally applied across domains involving increased discomfort stemming from episodic or recurrent symptom patterns. This medication is relevant for easing challenging symptoms due to allergies and hives.

This medicine is considered relevant for managing conditions characterized by periods of heightened symptoms, including seasonal hay fever (allergic rhinitis), perennial allergies, and both acute and chronic urticaria (hives).

“It offers supportive therapeutic benefit by easing the overall symptom load.”

Managing Respiratory and Ocular Allergic Symptoms

This medication helps address symptom clusters that typically appear suddenly or fluctuate, such as persistent sneezing, a runny nose, and the significant discomfort of itchy, watery eyes, which may interfere with daily functioning. The primary benefit is providing symptomatic relief that may help patients cope more steadily with symptom fluctuations, which supports general well-being during symptomatic phases.


Addressing Hives and Easing Symptoms of Allergic Skin Itching

Tomazine is applicable in conditions characterized by disruptive symptom manifestations on the skin, such as the itching (pruritus) and welts associated with hives. Often used when these symptoms create noticeable interference with functional stability, the medication offers supportive therapeutic benefit and may assist with easing the overall symptom load, which supports the patient during difficult episodes by easing distress.

Quick Fact: Supports Management of Allergic Symptom Manifestations
Respiratory Domain May assist with addressing sneezing and nasal discharge.
Ocular Domain Is relevant for managing itchy, watery eyes.
Cutaneous Domain May contribute to easing intense itching and lessening disruptive manifestations.

Regulatory References

  1. NIH MedlinePlus overview of Cetirizine

Eligibility and Restrictions for Use

Tomazine (Cetirizine Hydrochloride) eligibility is strictly defined by regulatory authorities based on age, physiological status, and allergy history.

Who Must Not Use Tomazine (Contraindications)

The medicine is contraindicated and must not be used by specific populations as defined in regulatory labeling:

  • Patients with documented hypersensitivity (allergy) to the active substance, its parent compound Hydroxyzine, or any piperazine derivatives.
  • Individuals with severe renal impairment or End-Stage Renal Disease (ESRD), as the drug is primarily eliminated by the kidneys.
  • Children under 6 years of age for the film-coated tablet formulation specifically, due to the inability to achieve accurate dose adaptation.

Condition-Based Eligibility and Restrictions

Use is restricted or requires caution in several groups:

  • Age: Adults and adolescents (12 years and older) are eligible for standard use. Liquid formulations are approved for infants as young as 6 months for specific indications.
  • Renal Function: Patients with moderate renal impairment are only eligible on the condition that the prescribed dose is formally reduced.
  • Caution: Official labeling advises caution for patients with a predisposition to urinary retention (e.g., prostatic hyperplasia) and in epileptic patients.
  • Pregnancy and Lactation: The drug should be used only if clearly necessary in pregnant women. Since Cetirizine is excreted into human milk, caution is advised when prescribing to lactating women.

What should I know about interactions with other medicines?

The interaction profile for Tomazine (Cetirizine Hydrochloride) is officially structured around pharmacodynamic and pharmacokinetic effects documented in government regulatory labeling. No drug-drug combination is formally listed as contraindicated.

Interacting Substances and Restrictions

The primary pharmacodynamic interaction involves Central Nervous System (CNS) Depressants and Alcohol. Regulatory documents advise against concurrent use with these substances as it may cause an additive reduction in alertness and impairment of performance. The drug is also a substrate of P-glycoprotein (P-gp), indicating that co-administration with P-gp inhibitors could potentially increase systemic exposure.

Pharmacokinetic Effects and Constraints

Formal pharmacokinetic studies show that Theophylline (400 mg/day) causes a small, documented decrease in the clearance of cetirizine. While the drug is not extensively metabolized by the Cytochrome P450 system, official labeling confirms that the presence of food alters the rate of absorption (e.g., peak concentration is delayed) without reducing the overall extent of absorption (AUC). No mandatory timing separation rules are documented for any interaction.

Population-Specific Notes

Official regulatory information notes that patient populations with Renal Impairment or Hepatic Impairment exhibit decreased clearance of cetirizine. This reduced physiological elimination leads to increased systemic exposure, which is an explicit constraint documented in the regulatory profile.

Mechanism of Action

How Tomazine Works

Tomazine is a molecular modulator that precisely engages specific biological systems to influence physiological activity. It exerts its pharmacodynamic effects by affecting signaling mechanisms across three distinct domains.

Tomazine acts primarily within the domain of receptor-mediated signaling, where it modifies the activity of key membrane-bound receptors. This action either initiates or suppresses downstream signaling sequences that control cellular communication, modulating physiological processes to decrease excessive activity within target systems.

The drug also targets enzyme-mediated signaling. By modifying the function of crucial intracellular enzymes, Tomazine alters early molecular steps in specific pathways. This action attenuates the production or effect of specific endogenous mediators and drives the affected pathway toward baseline or homeostatic activity.

Finally, Tomazine influences feedback regulation within pathways, which is essential for systemic balance. By engaging mechanisms that modulate pathway signal intensity, the drug determines subsequent changes in systemic physiological parameters, focusing exclusively on pharmacodynamic adjustments without reference to clinical outcomes.

Dosage and Administration Information

The official use of Tomazine (Cetirizine Hydrochloride) is defined by specific instructions concerning its two approved routes of administration: oral and intravenous (IV) injection. The oral forms—tablets, capsules, and solution—are generally used for continuous, single-dose regimens. The injectable product is reserved for specific acute conditions in controlled settings and is administered as an intravenous push over a period of 1 to 2 minutes.

For adults and adolescents 12 years of age and older, the standard oral regimen is 10 mg taken once daily, which represents the maximum dose permitted in a 24-hour period. A lower 5 mg dose may be used as a starting option for managing less severe symptoms. The medicine can be administered with or without food.

Since the medicine is primarily eliminated through the kidneys, official guidance requires a reduced dose for patients with impaired kidney function; for example, a maximum of 5 mg once daily is advised for moderate renal impairment. Dosing for pediatric patients is dependent on age and the specific product label, ranging from 2.5 mg to 10 mg daily.

When administering the oral solution, it is an official requirement to use the manufacturer-supplied measuring device to ensure accurate dosing. If a dose is missed, the patient should skip the missed dose and resume their regular schedule if it is near the next dose to prevent accidental double dosing.

Recent Clinical Evidence

Clinical Research Structure for Tomazine

Tomazine was primarily evaluated in short-term Randomized Controlled Trials (RCTs). These studies included adults, adolescents, and children (studied from 6 months to 2 years of age, depending on the condition) and explored how symptoms change over defined time intervals when compared to control groups, including those receiving a placebo or an active comparator.

Evidence Overview by Condition

For allergic rhinitis (hay fever and perennial allergies), research explored outcomes related to physical discomfort, measuring changes in specific symptoms and assessing Health-Related Quality of Life (HRQL) scores. Similarly, studies for chronic and acute urticaria (hives) examined patient-reported outcomes focused on the severity of itching (pruritus) and the physical presence of welts (wheals), tracked using standardized scores. The evidence quality for both areas, based on the volume and consistency of RCTs, is generally classified as High.

Research Gaps and Limitations

While a significant body of evidence exists, the pivotal trials establishing initial findings were predominantly short-term, typically lasting only a few weeks. This means long-term outcomes beyond these defined study windows are not fully established. Research describes these short-term patterns, but findings do not determine whether an individual will respond similarly over many years.

Furthermore, data for certain special populations remain insufficient. The research exploring short-term symptom changes in older adults (age 65 and over) is limited, and findings for this group are considered uncertain compared to younger adult populations. Results apply only to the populations studied, and there is limited information for long-term outcomes in these more complex age groups.

Frequently Asked Questions (FAQ)

Common questions about Tomazine (FAQ)


Q: How long does it typically take for Tomazine to start working?

Regulatory documents describe the timeframe for the drug to reach its highest level in the body. Official information states that peak plasma concentrations are typically reached within approximately 1 hour after taking a dose. This concentration level is used by researchers to describe the initial timeframe of the drug's activity.


Q: Is Tomazine generally appropriate for older adults?

Regulatory labeling addresses use in older adults primarily concerning kidney function. Official guidance notes that because a person's kidney function may naturally decline with age, the standard dose may need to be reduced for older adults with impaired kidney function. This dosage constraint is based on how the body eliminates the medicine.


Q: What happens if I forget to take a dose of Tomazine?

According to patient information from regulatory bodies, if a dose is missed and it is already close to the time for your next scheduled dose, the regulatory instruction provided is to skip the missed dose. The guidance provided is to continue with the regular schedule, and this approach aims to prevent accidental double dosing.


Q: What should I know about stopping Tomazine?

Official safety information notes a specific pattern that can occur after the medicine is stopped. Regulatory documents report that cases of severe pruritus (itching) or urticaria (hives) have been documented after patients discontinued long-term daily use of the medicine.


Q: Are there specific foods or drinks to avoid while taking Tomazine?

Regulatory documents describe the interaction between Tomazine and alcohol. Concurrent use is described as potentially causing an additive reduction in alertness and impairment of performance. The regulatory profile does not list restrictions regarding specific foods.


Q: Can Tomazine affect my ability to drive?

Official labeling advises caution regarding activities requiring mental alertness. Because the medicine has the potential to cause somnolence (drowsiness) in some patients, the official warning is tied to engaging in activities such as driving a car or operating machinery.


Q: Is Tomazine a controlled substance?

The active ingredient, Cetirizine Hydrochloride, is generally not included in the schedules for controlled substances maintained by regulatory bodies in major regions, such as the US DEA. This designation means it does not fall under strict control measures.


Q: What happens if I take too much Tomazine?

Regulatory documents list common symptoms reported after taking a dose significantly higher than recommended. These can include feeling restless or nervous, followed by drowsiness and sometimes dizziness or a rapid heartbeat (tachycardia). Official information emphasizes that potential signs of taking too much medicine warrant attention from a healthcare professional.


Q: Is Tomazine the same kind of medicine as [similar common drug name]?

Official classification defines Tomazine (Cetirizine Hydrochloride) as a second-generation antihistamine. Its official classification is a selective peripheral H1-receptor antagonist. It is derived from the older drug Hydroxyzine.


Q: Are there any serious side effects associated with Tomazine?

Rare and very rare reactions documented in regulatory labeling include events such as severe hypersensitivity (allergic reactions), convulsions, a rapid heart rate (tachycardia), and anaphylactic shock.


Q: Does Tomazine affect blood pressure?

While generally described as having a low potential for cardiovascular effects, regulatory documents note that very rare cases of severe hypotension (low blood pressure) have been documented in postmarketing reports.


Q: Can Tomazine be used by women who are pregnant or breastfeeding?

Regulatory documents describe the use during pregnancy with the condition that it is only if clearly necessary. Additionally, official information advises caution for use in women who are lactating or breastfeeding because the substance is known to be excreted into human milk.


Q: Is Tomazine available in a generic version?

Yes, regulatory records, such as the FDA's Orange Book, show that the active ingredient, Cetirizine Hydrochloride, is widely available in generic versions and is also sold under numerous brand names.


Q: What is the difference between Tomazine and its generic name?

The term Tomazine is a trade or brand name designated by a manufacturer for the medicine. Cetirizine Hydrochloride is the official generic name for the active pharmaceutical ingredient approved by regulatory authorities.


Q: Is it okay to take Tomazine every day?

Regulatory documents describe the standard oral regimen for continuous management as involving a single dose taken once daily. This pattern is the basis for its ongoing use in treating chronic conditions.


Q: What does the patient information leaflet say about Tomazine and mood changes?

Official regulatory documents list agitation as an uncommon side effect of the medicine. Rare postmarketing reports have also documented other psychological effects, including aggression, depression, and hallucination.


Q: What types of allergies are listed as concerns for Tomazine use?

The official regulatory profile lists specific contraindications (conditions that prohibit use). These include documented allergy or hypersensitivity to the active substance, its parent compound Hydroxyzine, or any substance known as a piperazine derivative.


Q: What is the legal status of Tomazine in different countries?

Regulatory decisions in major regions, including the US, Canada, and Australia, designate the drug's status. For common oral doses, it is typically designated as a non-prescription or over-the-counter (OTC) medicine.


Q: Does Tomazine have a Boxed Warning (Black Box Warning)?

No. Official drug safety records maintained by regulatory bodies such as the FDA do not list a Boxed Warning (also called a Black Box Warning) for Cetirizine Hydrochloride.

How should Tomazine be stored and disposed of?

Storage and Disposal Information

Official regulatory documents define strict requirements for storing and disposing of Tomazine (Chlorpromazine).

Storage Conditions

Requirement Specifics
Temperature Do not store above 25°C (tablets).
Protection Keep in the original package and protect from light.
Integrity Keep the container tightly closed to maintain stability.

Stability and Handling

Tomazine injection solution is photo-sensitive; if the solution develops a pink or yellow color upon light exposure, it must be discarded. Handling requires caution to avoid contact with the skin and eyes, particularly with liquid forms, and tablets should not be crushed. The shelf-life for tablets is documented as 3 years.

Disposal Rules

Any unused or expired product must be disposed of in accordance with local requirements using an approved waste disposal plant. The product must not enter drains, as it may be classified as a Hazardous Waste Pharmaceutical.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tomazine found in:

A-Z Index: